登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002044 证券简称：美年健康 公告编号：2026-012 美年大健康产业控股股份有限公司 第九届董事会第十八次（临时）会议 决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、董事会会议召开情况 美年大健康产业控股股份有限公司（以下简称"公司"）第九届董事会第十八次（临时）会议于2026年2 月13日以电子发送等形式发出会议通知，会议于2026年2月26日上午10时以通讯结合书面审议方式召 开。应出席本次会议的董事为9名，实际出席会议的董事为9名。会议由公司董事长俞熔先生主持，高级 管理人员列席了会议。本次会议的出席人数、召开表决程序、议事内容均符合《中华人民共和国公司 法》和《公司章程》等有关规定。 二、董事会会议审议情况 （一）审议并通过《关于批准本次交易相关的加期审计报告、备考审阅报告的议案》 鉴于本次交易相关文件中经审计的财务数据有效期届满，根据《中华人民共和国公司法》《中华人民共 和国证券法》《上市公司重大资产重组管理办法》《上市公司监管指引第9号一一上市公司筹划和实施 重大资 ...

中审众环会计师事务所作为美年健康发行股份购买资产的审计机构，就深交所关于美年健康申请发行股 份购买资产的审核问询函相关问题进行了回复。本次交易涉及收购16家标的公司股权，交易完成后上市 公司将直接及间接持有标的资产100%股权。 交易必要性与资金安排 问询函重点关注了交易必要性及资金支付方式。公司表示，本次收购是实际控制人履行承诺、解决同业 竞争的具体举措，同时有助于拓展健康体检服务的广度和深度，优化产业布局。尽管截至2025年3月31 日公司货币资金达22.99亿元，但经测算，公司最低现金保有量需135,256.94万元，加上安全储备资金 15,000万元及短期借款偿还准备64,988.20万元，资金存在一定压力。因此，通过发行股份收购标的资产 具有合理性，可避免流动性风险。 商誉减值风险提示 本次交易预计新增商誉2.75亿元，占2024年末净资产、总资产比例分别为3.15%、1.39%。公司已在重组 报告书中提示，若标的资产未来经营状况恶化，存在商誉减值风险。经敏感性分析，假设新增商誉减值 比例为20%，将导致2024年度净利润减少13.43%，净资产减少0.63%，总资产减少0.27%。 标的资产业绩波 ...

资料显示，美年大健康产业控股股份有限公司位于上海市静安区灵石路697号健康智谷9号楼三楼，成立 日期1991年1月22日，上市日期2005年5月18日，公司主营业务涉及健康体检、健康管理业务。主营业务 收入构成为：体检服务95.67%，其他服务4.33%。 华宝中证医疗ETF（512170）基金经理为张放。 截至发稿，张放累计任职时间5年28天，现任基金资产总规模356.41亿元，任职期间最佳基金回报 75.12%， 任职期间最差基金回报-23.7%。 2月24日，美年健康跌5.03%，截至发稿，报6.61元/股，成交5.53亿元，换手率2.08%，总市值258.73亿 元。 从美年健康十大流通股东角度 数据显示，华宝基金旗下1只基金位居美年健康十大流通股东。华宝中证医疗ETF（512170）三季度减 持1512.18万股，持有股数8866.4万股，占流通股的比例为2.29%。根据测算，今日浮亏损失约3103.24万 元。 华宝中证医疗ETF（512170）成立日期2019年5月20日，最新规模252.63亿。今年以来收益3.86%，同类 排名2811/5580；近一年收益5.73%，同类排名3928/429 ...

Core Viewpoint - Meinian Health is seeking to participate in the pre-restructuring of Bangjie Holdings, aiming to gain control of a company heavily in debt due to its foray into the photovoltaic industry, raising questions about the strategic rationale behind this move [1] Group 1: Meinian Health's Financial Performance - Meinian Health reported a total revenue of 10.702 billion yuan in 2024, a year-on-year decrease of 1.76% [1] - The net profit attributable to shareholders was 282 million yuan, down 44.18% year-on-year [1] - The company's gross margin was 42.78%, a slight decrease of 0.01 percentage points, while the net margin fell to 3.82%, a decrease of 37.75% year-on-year [1] - The decline in performance is attributed to a reduction in the number of health check-ups and intensified industry competition [1] Group 2: Debt Structure and Financial Health - As of the end of Q3 2025, Meinian Health had cash and cash equivalents of 2.011 billion yuan, with short-term borrowings and current liabilities exceeding 3.9 billion yuan [1] - The company’s interest-bearing debt reached 6.338 billion yuan, continuing to rise slightly year-on-year [1] - The high debt levels contrast sharply with the company's weak profitability, indicating insufficient financial flexibility [1] Group 3: Bangjie Holdings' Financial Troubles - Bangjie Holdings, originally focused on seamless clothing, invested over 10 billion yuan in the photovoltaic sector starting in 2022, but faced severe challenges due to price wars and tightened financing [2] - The company announced the termination of an 8 billion yuan photovoltaic project and has accumulated overdue debts totaling 969 million yuan [2] - As of the end of Q3 2025, Bangjie Holdings had a debt-to-asset ratio of 138.88%, with cash reserves of only 150 million yuan against interest-bearing debts of 1.9 billion yuan [2] - The company has incurred cumulative losses exceeding 1.6 billion yuan from 2023 to Q3 2025, with a net loss of 672 million yuan in 2024 and 905 million yuan in the first three quarters of 2025 [2] Group 4: Risks and Challenges of the Acquisition - Meinian Health's participation in Bangjie Holdings' restructuring may require significant capital investment to settle debts and restore operations, which could strain its own liquidity [2][3] - The ongoing losses from Bangjie Holdings' photovoltaic business and outstanding debts may negatively impact Meinian Health's overall profitability even after restructuring [3] - Meinian Health faces management challenges due to a lack of operational experience in the photovoltaic sector, compounded by the uncertainties surrounding Bangjie Holdings' assets [3] Group 5: Industry Analyst Insights - Industry analysts suggest that the photovoltaic sector is not a reliable lifeline for Meinian Health, as latecomers lack cost advantages, and halting production may be the only viable option for Bangjie Holdings [4] - The high-risk nature of this cross-industry acquisition is underscored by Meinian Health's own financial pressures and Bangjie Holdings' significant debt and ongoing losses [4] - The success of this "cross-industry marriage" will depend on the design of the restructuring plan and Meinian Health's ability to maintain its financial safety while supporting the new business [4]

面对每天上千份上市公司公告该看哪些？重大事项公告动辄几十页几百页重点是啥？公告里 一堆专业术语不知道算利好还是利空？请看智通财经公司新闻部《速读公告》栏目，我们派 驻全国的记者们将于公告当晚为您带来准确、快速、专业的解读。 智通财经1月29日讯（记者 陈夏筱）为了拓展业务布局，体检龙头企业美年健康（002044.SZ）计划参 与棒杰股份（002634.SZ）的预重整。 今日晚间，公司发布公告称，公司第九届董事会第十七次会议审议通过了《关于拟参与浙江棒杰控股集 团股份有限公司预重整的议案》，同意公司作为意向投资者参与棒杰股份重整投资人的公开招募，并指 定下属全资子公司美年大健康为重整受让主体取得棒杰股份的控制权，成为棒杰股份重整完成后的控股 股东。 2025年3月1日，棒杰股份扬州工厂宣布全线停工停产，原计划3个月的检修期结束后，工厂再无力复 产。2025年7月，棒杰股份宣布江山光伏项目终止，并向地方政府支付1500万元赔偿款，公司跨界光伏 的努力全面归零。此时，棒杰股份光伏板块逾期债务总额据披露已达9.67亿元。 2025年7月，上海启烁睿行通过受让股份成为公司新控股股东，黄荣耀成为新的实际控制人。 财务数据 ...

致敬词： 他被称为"中国飞行摩托第一人"。从洞庭湖畔的少年，到全球低空经济浪潮的破局者，他用十余年时 间，将儿时的梦想变为现实。从热爱飞行，到造出中国首款飞行摩托，再到打造全球首条飞行汽车量产 线，他以敢闯敢拼的韧劲攻坚克难，带领汇天成长为亚洲规模最大的飞行汽车公司。他不仅让中国人造 飞行器腾空而起，更推动中国低空经济实现从技术研发到规模量产的跨越式突破。 专题：为中国经济点赞——企业家之夜2025盛典 "为中国经济点赞——企业家之夜"于1月29日在北京举行。汇天创始人赵德力出席接受致敬。爱康集团 创始人、董事长兼CEO张黎刚与国能中电能源集团董事长、中国青年企业家协会副会长、盘古智库执行 理事长白云峰为其见证荣誉。 张黎刚谈到，中国每年超过250万人死于心脏病，其中50万人死于心脏猝死，黄金救援仅仅4到6分钟， 但是救护车4到6分钟是不会到的。所以，希望汇天汽车能够在4到6分钟中，把专家跟除颤仪送到现场， 拯救更多的生命。 白云峰提到，人类历次产业革命都是从三个维度开始发生的，首先是能源的变化——现在已经进入绿色 能源时代，其次是通信的变化——AI人工智能的时代已经来临，最重要的还有一个交通维度——从传 统 ...

爱康国宾旗下的广州环市东分院，从2005年6月开业至今20年，分院的信誉度、客户忠诚度逐年提升。 细致暖心的健康服务、专业品质的健康体检、舒适温馨的体检环境，获得客户一致好评。 环市东分院二层为爱康国宾VIP贵宾体检区域，检区分为A/B/C/D/W(女宾区)；三层爱康国宾普检区 域，检区分为A/B/C/D/E/F/G/H/I/W(女宾区)；四层爱康卓悦体检区域，检区分为V1/V2/V3/V5/V6/V7/女 宾区，各个检区布局合理，各检室采用一对一包间式设计，充分保护客人的隐私。独特而完备的流程， 为客户的体检数据提供最大化的隐私保护，并将其完好保存，私密的体检服务，让体检旅程更加舒适安 心。 环市东分院二层 VIP区 环市东分院四层 环市东分院三层 精准体检 至诚服务 舒适便捷 悦享健康 广州爱康环市东分院地理位置优越，地处广州市首个CBD—环市东商圈，位于环市东路广发花园大厦 2、3、4层，面积达11000平米，毗邻城市主干道环市路，交通便利，周边公共交通网络发达，距广州地 铁五号线动物园站C出口仅500米，其舒适、温馨的体检环境，尽享会所级服务的体检过程，让体检成 为一种享受。 二十载耕耘，客户的认可与 ...

Group 1 - The core viewpoint of the news is that Meinian Health has experienced a significant stock price increase, rising 9.99% to 8.15 CNY per share, with a total market capitalization of 31.901 billion CNY and a cumulative increase of 36.97% over four consecutive days [1] - Meinian Health, established on January 22, 1991, and listed on May 18, 2005, primarily engages in health check-ups and health management services, with 95.67% of its revenue coming from health check services [1] - The trading volume for Meinian Health reached 211 million CNY, with a turnover rate of 0.67% [1] Group 2 - From the perspective of major fund holdings, one fund under Xingzheng Global has a significant position in Meinian Health, with the fund reducing its holdings by 3.49 million shares to 9.8964 million shares, representing 3.25% of the fund's net value [2] - The fund, Xingquan Zhongzheng 800 Six-Month Holding Index Enhanced A, has generated a floating profit of approximately 7.3233 million CNY today and 19.7928 million CNY during the four-day price increase [2] - The fund was established on February 9, 2021, with a current scale of 1.37 billion CNY and has achieved a year-to-date return of 5.92% [2]

Core Viewpoint - The AI healthcare sector is experiencing significant activity, with companies like Meinian Health and Guoxin Health reaching their daily price limits following the announcement of OpenAI's ChatGPT Health, indicating a strong market interest in AI-driven healthcare solutions [1][3]. Group 1: Market Performance - On January 9, the Shanghai Composite Index broke the 4100-point mark for the first time in 10 years, with a trading volume of 2.06 trillion yuan, an increase of 296.3 billion yuan compared to the previous trading day [1]. - Meinian Health (002044) reached a limit-up price of 6.13 yuan per share, with a price-to-earnings ratio of 347.01 and a total market capitalization of 23.99 billion yuan [1]. Group 2: Company Overview - Meinian Health is a leading health examination and medical service group in China, focusing on health examination services with brands like "Meinian Health," "Ciming Health Examination," "Ciming Aoya," and "Meizhao Health," establishing a multi-tiered service system [1]. - As of Q3 2025, Meinian Health operates 561 health examination centers across over 300 cities in China, including 300 wholly-owned branches, creating a nationwide service network [1]. Group 3: AI Strategy - Meinian Health's AI strategy encompasses three main areas: product innovation, process optimization, and ecosystem development [3]. - The company has launched several AI medical products, including "Lung Jie Ning," "Nerve Rui Jia," and "AI-MDT Report," covering early screening, diagnosis, and health management [3]. - The "Nerve Rui Jia" product utilizes high-precision brain MRI and deep learning technology to identify early brain lesions, becoming a flagship product for the company [3]. - The "Health Xiao Mei" AI smart health management system has been implemented in 217 health examination centers, generating over 3 million health examination reports and reducing report review time from an average of 2 minutes to 0.7 minutes, improving process efficiency by over 50% [3].

Group 1 - The core viewpoint of the news is that Meinian Health has seen a significant stock price increase of 7.36%, reaching 5.98 CNY per share, with a trading volume of 256 million CNY and a market capitalization of 23.407 billion CNY as of January 9 [1] - Meinian Health is primarily engaged in health check-ups and health management services, with 95.67% of its revenue coming from health check-up services and 4.33% from other services [1] Group 2 - From the perspective of major fund holdings, Yinhua Fund has a significant position in Meinian Health, with its Yinhua Medical Health Mixed A Fund (018364) increasing its holdings by 38,600 shares to a total of 550,200 shares, representing 4.91% of the fund's net value [2] - The Yinhua Medical Health Mixed A Fund was established on September 6, 2023, with a current size of 37.2991 million CNY and has achieved a year-to-date return of 11.26%, ranking 141 out of 8,827 in its category [2] - The fund manager Zhang Ping has a tenure of 7 years and 67 days, with a total asset size of 20.107 billion CNY, achieving a best return of 200.77% and a worst return of -37.99% during her tenure [3]